These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38521510)

  • 1. Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Abe K; Kitahara H; Suzuki S; Hiraga T; Yamazaki T; Ohno Y; Harada J; Fukushima K; Asano T; Ishio N; Uchiyama R; Miyahara H; Okino S; Sano M; Kuriyama N; Yamamoto M; Sakamoto N; Kanda J; Kobayashi Y
    Int J Cardiol; 2024 Jun; 405():131989. PubMed ID: 38521510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of anemia on percutaneous coronary intervention in Chinese patients: A large single center data.
    Jiang L; Gao Z; Song Y; Xu J; Tang X; Wang H; Liu R; Jiang P; Xu B; Yuan J
    J Interv Cardiol; 2018 Dec; 31(6):826-833. PubMed ID: 30467893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    Kitahara H; Yamashita D; Sato T; Suzuki S; Hiraga T; Yamazaki T; Matsumoto T; Kobayashi T; Ohno Y; Harada J; Fukushima K; Asano T; Ishio N; Uchiyama R; Miyahara H; Okino S; Sano M; Kuriyama N; Yamamoto M; Sakamoto N; Kanda J; Kobayashi Y
    J Cardiol; 2023 Sep; 82(3):207-214. PubMed ID: 37336423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive accuracy of CHA2DS2-VASc and HAS-BLED scores in patients without atrial fibrillation undergoing percutaneous coronary intervention and discharged on dual antiplatelet therapy.
    Capodanno D; Rossini R; Musumeci G; Lettieri C; Senni M; Valsecchi O; Angiolillo DJ; Lip GY
    Int J Cardiol; 2015 Nov; 199():319-25. PubMed ID: 26241637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Puurunen M; Kiviniemi T; Nammas W; Schlitt A; Rubboli A; Nyman K; Karjalainen P; Kirchhof P; Lip GY; Airaksinen JK
    BMJ Open; 2014 May; 4(5):e004700. PubMed ID: 24823675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention.
    Faggioni M; Baber U; Sartori S; Chandrasekhar J; Cohen DJ; Henry TD; Claessen BE; Dangas GD; Gibson CM; Krucoff MW; Vogel B; Moliterno DJ; Sorrentino S; Colombo A; Chieffo A; Kini A; Farhan S; Ariti C; Witzenbichler B; Weisz G; Steg PG; Pocock S; Mehran R
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007133. PubMed ID: 30998384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time in therapeutic range and major adverse outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: The Atrial Fibrillation Undergoing Coronary Artery Stenting (AFCAS) registry.
    Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GY;
    Am Heart J; 2017 Aug; 190():86-93. PubMed ID: 28760217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
    De Luca L; Rubboli A; Bolognese L; Uguccioni M; Lucci D; Blengino S; Campodonico J; Meynet I; Brach Prever SM; Di Lenarda A; Gabrielli D; Gulizia MM;
    Open Heart; 2021 Jul; 8(2):. PubMed ID: 34261777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of octogenarians with atrial fibrillation undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Lahtela HM; Bah A; Kiviniemi T; Nammas W; Schlitt A; Rubboli A; Karjalainen PP; Proietti M; Hartikainen JEK; Lip GYH; Airaksinen KEJ
    Clin Cardiol; 2017 Dec; 40(12):1264-1270. PubMed ID: 29243834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the Atrial Fibrillation undergoing Coronary Artery Stenting study.
    Schlitt A; Rubboli A; Lip GY; Lahtela H; Valencia J; Karjalainen PP; Weber M; Laine M; Kirchhof P; Niemelä M; Vikman S; Buerke M; Airaksinen KE;
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E864-70. PubMed ID: 23765437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
    Caballero L; Ruiz-Nodar JM; Marín F; Roldán V; Hurtado JA; Valencia J; Manzano-Fernandez S; Sogorb F; Valdes M; Lip GY
    Age Ageing; 2013 Jan; 42(1):70-5. PubMed ID: 22983982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study.
    Zhang Z; Jiang C; He L; Bai Y; Wu J; Hu R; Lv Q; Ning M; Feng L; Tang R; Sang C; Long D; Dong J; Du X; Lip GYH; Ma C
    Clin Cardiol; 2022 Jan; 45(1):91-100. PubMed ID: 34964140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of mid-term outcomes between patients with and without atrial fibrillation undergoing coronary stenting in the second-generation drug-eluting stent era: from the SHINANO registry.
    Miura T; Miyashita Y; Motoki H; Kobayashi H; Kobayashi M; Nakajima H; Kimura H; Akanuma H; Mawatari E; Sato T; Hotta S; Kamiyoshi Y; Maruyama T; Watanabe N; Eizawa T; Aso S; Uchikawa S; Hashizume N; Senda K; Morita T; Ebisawa S; Izawa A; Koyama J; Ikeda U
    Cardiovasc Interv Ther; 2017 Jul; 32(3):206-215. PubMed ID: 27311986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Impact of Baseline Hemoglobin Levels on Long-Term Thrombotic and Bleeding Events After Percutaneous Coronary Interventions.
    Nagao K; Watanabe H; Morimoto T; Inada T; Hayashi F; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Natsuaki M; Kozuma K; Tanabe K; Morino Y; Shiomi H; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013703. PubMed ID: 31701786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention.
    Hosseini SK; Ansari MJ; Lotfi Tokaldany M; Sharafi A; Hakki Kazazi E; Poorhosseini H
    J Cardiovasc Med (Hagerstown); 2014 Apr; 15(4):331-5. PubMed ID: 23422885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.
    Kitai Y; Ozasa N; Morimoto T; Bao B; Furukawa Y; Nakagawa Y; Kadota K; Yanagita M; Shizuta S; Kimura T;
    Int J Cardiol; 2013 Oct; 168(6):5221-8. PubMed ID: 23998544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.
    Proietti M; Airaksinen KEJ; Rubboli A; Schlitt A; Kiviniemi T; Karjalainen PP; Lip GYH;
    Clin Res Cardiol; 2017 Jun; 106(6):420-427. PubMed ID: 28078448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    Ang L; Behnamfar O; Palakodeti S; Lin F; Pourdjabbar A; Patel MP; Reeves RR; Mahmud E
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.